Form 4: Orthofix Executive Sells Shares for Tax Obligations
Insider Transaction Report
Orthofix Medical Inc.'s President of Global Spine, Max Reinhardt, sold shares to cover tax withholding obligations related to restricted stock unit settlements.
Summary
- Max Reinhardt, President, Global Spine at Orthofix Medical Inc. (OFIX), reported sales of common stock.
- On March 4, 2026, 1,080 shares were sold at a weighted average price of $12.9163 per share.
- On March 5, 2026, an additional 1,053 shares were sold at a weighted average price of $12.5508 per share.
- These sales were non-discretionary, executed to satisfy tax withholding obligations upon the settlement of restricted stock units, as per a pre-existing sell-to-cover requirement approved by the Compensation and Talent Development Committee.
- Following these transactions, Reinhardt beneficially owns 25,348 shares of common stock, which includes 19,417 previously reported restricted stock units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sales were non-discretionary and solely for tax withholding purposes, which is a standard practice for executive equity compensation.
Management Comments
- The sale was made without the exercise of any discretion by the reporting person.
Industry Context
StockSavvy.ai notes that routine 'sell-to-cover' transactions for tax obligations are common for executives receiving equity compensation and are generally not indicative of management's sentiment towards the company's future performance, unlike discretionary sales.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Adherence | The sales were executed pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors, which administers the equity plan. | NA | Demonstrates adherence to established corporate governance policies regarding executive equity compensation and tax obligations. |
Stakeholder Impact
- Shareholders: Minimal impact as these are routine, non-discretionary sales for tax purposes and do not signal a change in management's confidence or company fundamentals.
Key Dates
| Date | Description |
|---|---|
| 03/04/2026 | Sale of 1,080 shares of common stock by Max Reinhardt to satisfy tax withholding obligations. |
| 03/05/2026 | Sale of 1,053 shares of common stock by Max Reinhardt to satisfy tax withholding obligations. |
| 03/06/2026 | Date of filing signature by J. Andres Cedron, Attorney-in-fact. |
Recommendation
holdThe reported transactions are routine 'sell-to-cover' sales to satisfy tax obligations related to restricted stock unit settlements. These are non-discretionary and do not reflect a change in the insider's investment sentiment or the company's fundamentals, thus warranting no change in investment recommendation based solely on this filing.
Keywords
Orthofix Medical Inc., OFIX, insider trading, Form 4, stock sale, tax withholding, restricted stock units, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.